Impact of Low-Dose Irradiation of the Lung and Heart on Toxicity and Pulmonary Function Parameters after Thoracic Radiotherapy
- PMID: 33374564
- PMCID: PMC7793060
- DOI: 10.3390/cancers13010022
Impact of Low-Dose Irradiation of the Lung and Heart on Toxicity and Pulmonary Function Parameters after Thoracic Radiotherapy
Abstract
Objective: To assess the impact of (low) dose irradiation to the lungs and heart on the incidence of pneumonitis and pulmonary function changes after thoracic radiotherapy (RT). Methods/Material: Data of 62 patients treated with curative thoracic radiotherapy were analyzed. Toxicity data and pulmonary function tests (PFTs) were obtained before RT and at 6 weeks, at 12 weeks, and at 6 months after RT. PFTs included ventilation (e.g., vital capacity) and diffusion parameters (e.g., diffusion capacity for carbon monoxide (DLCO)). Dosimetric data of the lung and heart were extracted to assess the impact of dose on PFT changes and radiation pneumonitis (RP).
Results: No statistically significant correlations between dose parameters and changes in ventilation parameters were found. There were statistically significant correlations between DLCO and low-dose parameters of the lungs (V5Gy-V30Gy (%)) and irradiation of the heart during the follow-up up to 6 months after RT, as well as a temporary correlation of the V60Gy (%) on the blood gas parameters at 12 weeks after RT. On multivariate analysis, both heart and lung parameters had a significant impact on DLCO. There was no statistically significant influence of any patient or treatment-related (including dose parameters) factors on the incidence of ≥G2 pneumonitis.
Conclusion: There seems to be a lasting impact of low dose irradiation to the lung as well as irradiation to the heart on the DLCO after thoracic radiotherapy. No influence on RP was found in this analysis.
Keywords: lung neoplasms; organs at risk; radiation injuries; respiratory function tests.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Physical and biological predictors of changes in whole-lung function following thoracic irradiation.Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):563-70. doi: 10.1016/s0360-3016(97)00343-x. Int J Radiat Oncol Biol Phys. 1997. PMID: 9336133
-
Changes in pulmonary function and influencing factors after high-dose intrathoracic radio(chemo)therapy.Strahlenther Onkol. 2017 Feb;193(2):125-131. doi: 10.1007/s00066-016-1067-8. Epub 2016 Oct 25. Strahlenther Onkol. 2017. PMID: 27783103 Clinical Trial. English.
-
Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1381-8. doi: 10.1016/j.ijrobp.2006.03.008. Epub 2006 Jun 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16757130
-
Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.Cancer. 2002 Jun 1;94(11):2821-9. doi: 10.1002/cncr.10573. Cancer. 2002. PMID: 12115368 Review.
-
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):5-24. doi: 10.1016/j.ijrobp.2005.03.047. Int J Radiat Oncol Biol Phys. 2005. PMID: 15963660 Review.
Cited by
-
Advances in Lung Cancer Imaging and Therapy.Cancers (Basel). 2021 Dec 23;14(1):58. doi: 10.3390/cancers14010058. Cancers (Basel). 2021. PMID: 35008219 Free PMC article.
-
Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: analysis of organs at risk by dose and its effect on blood kinetics.J Cancer Res Clin Oncol. 2023 Aug;149(10):7007-7015. doi: 10.1007/s00432-023-04657-7. Epub 2023 Mar 1. J Cancer Res Clin Oncol. 2023. PMID: 36856852 Free PMC article.
-
Lung sparing and ribcage coverage in total body irradiation delivered by helical tomotherapy.Eur J Med Res. 2022 Dec 10;27(1):287. doi: 10.1186/s40001-022-00918-2. Eur J Med Res. 2022. PMID: 36496388 Free PMC article.
-
Hybrid VMAT-3DCRT as breast cancer treatment improvement tool.Sci Rep. 2024 Jan 3;13(1):23110. doi: 10.1038/s41598-023-50538-x. Sci Rep. 2024. PMID: 38172237 Free PMC article.
-
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress.EJNMMI Radiopharm Chem. 2025 Jun 21;10(1):32. doi: 10.1186/s41181-025-00356-5. EJNMMI Radiopharm Chem. 2025. PMID: 40542914 Free PMC article. Review.
References
-
- Stanic S., Paulus R., Timmerman R.D., Michalski J.M., Barriger R.B., Bezjak A., Videtic G.M.M., Bradley J. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: An analysis of RTOG 0236. Int. J. Radiat. Oncol. Biol. Phys. 2014;88:1092–1099. doi: 10.1016/j.ijrobp.2013.12.050. - DOI - PMC - PubMed
-
- Jaen J., Vazquez G., Alonso E., De las Penas M., Diaz L., De las Heras M., Perez-Regadera J. Long-term Changes in Pulmonary Function After Incidental Lung Irradiation for Breast Cancer: A Prospective Study With 7-Year Follow-up. Int. J. Radiat. Oncol. Biol. Phys. 2012;84:e565–e570. doi: 10.1016/j.ijrobp.2012.07.003. - DOI - PubMed
LinkOut - more resources
Full Text Sources